The 13% year-over-year increase in Q4 billings for DocuSign is a positive indicator of the company's growth and operational performance. This is likely to be viewed favorably by investors, potentially leading to a short-term increase in the stock price. The direct correlation between earnings performance and stock price movements supports this analysis.